SEC Tracker
Get the app

Editas Medicine EDIT

Editas Medicine reported a net loss of $23.39 million for Q3 2026.

Editas Medicine (EDIT) filed a 10-Q with the SEC on Nov 9, 2026, 4:10 pm ET. Source: the filing on SEC EDGAR.

Form
10-Q
Filed
Importance
Notable
  1. Revenue was $10.37 million for the three months ended Sep 30, 2026.
  2. Net loss was $23.39 million for the three months ended Sep 30, 2026.
  3. Cash and equivalents were $93.17 million as of Sep 30, 2026.

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Editas Medicine files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.